Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO(BMY) · Entity 1662 | SVP, Global Reg Sciences | March 07, 2006 | March 09, 2006 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BRISTOL MYERS SQUIBB CO
Report date March 07, 2006 · Filed March 09, 2006
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.10 par valueSEC Table I · non-derivative | Direct | 45,016 |
Ending reported balance
After 2006-03-07 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2006-03-07 · Grant · Acquired 5,750 · Balance 42,917 F1: Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Row 2 · 2006-03-07 · Grant · Acquired 3,304 · Balance 46,221 F2: Consists of shares earned as long-term performance awards under the 2002 Stock Incentive Plan. Row 3 · 2006-03-07 · Tax withholding · Disposed 1,205 · Balance 45,016 F3: Shares withheld for payment of taxes. |
| Executive Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $22.73 · Expires 2016-03-06 | Direct | 23,920 |
Reported balance
After 2006-03-07 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2006-03-07 · Grant · Acquired 23,920 · Balance 23,920 F4: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Option vests 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant, but may not be exercised until the threshold is satisfied. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date.
F2: Consists of shares earned as long-term performance awards under the 2002 Stock Incentive Plan.
F3: Shares withheld for payment of taxes.
F4: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Option vests 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant, but may not be exercised until the threshold is satisfied.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 07, 2006 Filed Mar 9, 2006 22:10 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantExecutive Option (right to buy) · Derivative | 23,920 | $0.00 Strike: $22.73 | $0.00 |
DisclosureSEC source: 0000014272-06-000105 · wol534.xml · derivative · entry 4 Wolgemuth Richard L · CIK 0001333807 · SVP, Global Reg Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,920 Underlying: Common Stock, $0.10 par value · 23,920 shares Expires 2016-03-06 F4 · derivative.exercise_date: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Option vests 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant, but may not be exercised until the threshold is satisfied. Read SEC document |
| March 07, 2006 Filed Mar 9, 2006 22:10 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,205 | $22.73 | $27,389.65 |
DisclosureSEC source: 0000014272-06-000105 · wol534.xml · nonDerivative · entry 3 Wolgemuth Richard L · CIK 0001333807 · SVP, Global Reg Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,016 F3 · shares: Shares withheld for payment of taxes. Read SEC document |
| March 07, 2006 Filed Mar 9, 2006 22:10 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantCommon Stock, $0.10 par value | 3,304 | $22.73 | $75,099.92 |
DisclosureSEC source: 0000014272-06-000105 · wol534.xml · nonDerivative · entry 2 Wolgemuth Richard L · CIK 0001333807 · SVP, Global Reg Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,221 F2 · shares: Consists of shares earned as long-term performance awards under the 2002 Stock Incentive Plan. Read SEC document |
| March 07, 2006 Filed Mar 9, 2006 22:10 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantCommon Stock, $0.10 par value | 5,750 | $22.73 | $130,697.50 |
DisclosureSEC source: 0000014272-06-000105 · wol534.xml · nonDerivative · entry 1 Wolgemuth Richard L · CIK 0001333807 · SVP, Global Reg Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,917 F1 · shares: Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.